20.2. Analysis.

Comparison 20 BPO/erythromycin versus clindamycin, Outcome 2 Percentage of participants with any adverse events (long‐term data).

Comparison 20 BPO/erythromycin versus clindamycin, Outcome 2 Percentage of participants with any adverse events (long‐term data).